297 related articles for article (PubMed ID: 23147976)
1. Successful tocilizumab treatment in a child with refractory Takayasu arteritis.
Bravo Mancheño B; Perin F; Guez Vázquez Del Rey Mdel M; García Sánchez A; Alcázar Romero PP
Pediatrics; 2012 Dec; 130(6):e1720-4. PubMed ID: 23147976
[TBL] [Abstract][Full Text] [Related]
2. One-year clinical and radiological evolution of a patient with refractory Takayasu's arteritis under treatment with tocilizumab.
Bredemeier M; Rocha CM; Barbosa MV; Pitrez EH
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S98-100. PubMed ID: 22410201
[TBL] [Abstract][Full Text] [Related]
3. Blind runner.
Pelegrín L; Mesquida M; Rey A; Sánchez-Dalmau B; Frohman L
Surv Ophthalmol; 2012 Sep; 57(5):486-94. PubMed ID: 22018675
[TBL] [Abstract][Full Text] [Related]
4. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis.
Lo Gullo A; Mandraffino G; Aragona CO; Molica Colella A; Saitta A; Imbalzano E
Reumatismo; 2017 Dec; 69(4):184-188. PubMed ID: 29320845
[TBL] [Abstract][Full Text] [Related]
6. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
[TBL] [Abstract][Full Text] [Related]
7. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
Goel R; Danda D; Kumar S; Joseph G
Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
[TBL] [Abstract][Full Text] [Related]
8. [Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
Frikha F; Garbaa S; Bouattour Y; Snoussi M; Loukil H; Ben Salah R; Bahloul Z
J Med Vasc; 2019 May; 44(3):237-239. PubMed ID: 31029281
[TBL] [Abstract][Full Text] [Related]
9. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous revascularization of sole arch artery for severe cerebral ischemia resulting from Takayasu arteritis.
Tyagi S; Gupta MD; Singh P; Shrimal D; Girish MP
J Vasc Interv Radiol; 2008 Dec; 19(12):1699-703. PubMed ID: 18952463
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
[TBL] [Abstract][Full Text] [Related]
13. Tocilizumab for the treatment of patients with refractory Takayasu arteritis.
Nakaoka Y; Higuchi K; Arita Y; Otsuki M; Yamamoto K; Hashimoto-Kataoka T; Yasui T; Ikeoka K; Ohtani T; Sakata Y; Shima Y; Kumanogoh A; Yamauchi-Takihara K; Tanaka T; Kishimoto T; Komuro I
Int Heart J; 2013; 54(6):405-11. PubMed ID: 24309452
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
Kong X; Zhang X; Lv P; Cui X; Ma L; Chen H; Liu H; Lin J; Jiang L
Int J Cardiol; 2018 Sep; 266():222-228. PubMed ID: 29729868
[TBL] [Abstract][Full Text] [Related]
15. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
Osman M; Emery D; Yacyshyn E
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab in refractory aortitis: study on 16 patients and literature review.
Loricera J; Blanco R; Castañeda S; Humbría A; Ortego-Centeno N; Narváez J; Mata C; Melchor S; Aurrecoechea E; Calvo-Alén J; Lluch P; Moll C; Mínguez M; Herrero-Beaumont G; Bravo B; Rubio E; Freire M; Peiró E; González-Vela C; Rueda-Gotor J; Pina T; Palmou-Fontana N; Calvo-Río V; Ortiz-Sanjuán F; González-Gay MÁ
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S79-89. PubMed ID: 24854377
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.
Nishimoto N; Nakahara H; Yoshio-Hoshino N; Mima T
Arthritis Rheum; 2008 Apr; 58(4):1197-200. PubMed ID: 18383395
[TBL] [Abstract][Full Text] [Related]
20. Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
Yokokawa T; Kunii H; Kaneshiro T; Ichimura S; Yoshihisa A; Yashiro Furuya M; Asano T; Nakazato K; Ishida T; Migita K; Takeishi Y
BMC Cardiovasc Disord; 2019 Apr; 19(1):79. PubMed ID: 30940076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]